Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials-Reference-Cited by-同舟云学术

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

Published:2015-11-24 Issue:6 Volume:30 Page:1428-1430
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hoster E, ,Geisler C H,Doorduijn J,van der Holt B,Walewski J,Bloehdorn J,Ribrag V,Salles G,Hallek M,Pott C,Szymczyk M,Kolstad A,Laurell A,Räty R,Jerkeman M,van't Veer M,Kluin-Nelemans J C,Klapper W,Unterhalt M,Dreyling M,Hermine O

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015322.pdf

Reference12 articles.

1. Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O et al. ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 2013; 24: 857–877.

2. Rubio MT, Boumendil A, Luan JJ, Canals C, Lefrere F, Attal M et al. Is there still a place for total body irradiation (TBI) in the conditioning regimen of autologous stem cell transplantation in mantle cell lymphoma?: a retrospective study from the lymphoma working party of the EBMT. Blood (ASH Annual Meeting Abstracts) 2010; 116, abstract 688.

3. Peterlin P, Leux C, Gastinne T, Roland V, Mahe B, Dubruille V et al. Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients? Transplantation 2012; 94: 295–301.

4. Robinson S, Dreger P, Caballero D, Corradini P, Geisler C, Ghielmini M et al. The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. Leukemia 2015; 29: 464–473.

5. Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 2008; 112: 2687–2693.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis;Annals of Hematology;2023-08-08

2. Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406;Cancer Science;2023-05-26

3. Mantelzelllymphom;Indolente Lymphome;2023

4. Hematopoietic cell transplantation for mantle cell lymphoma;International Journal of Hematology;2022-01-29

5. Cellular Therapies for Mantle Cell Lymphoma;Transplantation and Cellular Therapy;2021-05